The FDA, on February 25, 2015 issued a new safety announcement for the revision of the label for diabetic pens and packaging of multiple doses to carry a warning label stating, “For single patient use only”.
Hypoglycemia is common in type 1 diabetes and also common in type 2 diabetes. Hypoglycemia unawareness can occur after repeated episodes of hypoglycemia and is of great concern due to the risk of severe hypoglycemia.
Each year, the Advisory Committee on Immunization Practices (ACIP) reviews the recommended adult (anyone over 18 years old) and children 18 years and younger, immunization schedule to ensure that the schedules reflects current recommendations for the licensed vaccines.
This activity will examine practical evidence-based techniques for selecting and implementing weight loss options to improve health outcomes in overweight patients. Focus will be on engaging patients to promote adherence in weight loss programs that meet their individual needs, including those that use weight loss medications.
Diabetic retinopathy is found in nearly 30% of diabetic patients over 40 years of age and is the leading cause of new cases of blindness in adults ages 20-74. This educational activity will reinforce traditional strategies, and educate clinicians about new strategies, for managing the eye health of patients with diabetes.
This CME article will present the clinical realities of obesity encouraging an open provider/patient relationship that enhances care, allowing for discussions on goals, adherence, barriers, and expectations.
This activity will provide the participant with the latest up-to-date information for thyroid disease and review of treatment for both subclinical and overt disease. Discussion will include management of therapeutic options as well as counseling, screening, and monitoring the pregnant thyroid patient.
By age 85, most individuals have some degree of frailty and health conditions requiring chronic therapy, and among these health conditions, anemia is exceptionally common. This activity is designed to guide clinicians through the differential diagnosis of geriatric anemia, to narrow differential diagnosis and guide subsequent evaluation.
The four 0.5-credit modules in this Virtual Practice activity have been developed to improve the general understanding of the diagnosis and management of shift work disorder. A scientific presentation and three case studies are presented.
This activity will provide the attendee with the latest up-to-date information and state-of-the-art management strategies using oral antiplatelet drugs for Acute Coronary Syndrome patients based on the 2013 ACC/AHA Guidelines.
This educational activity will discuss appropriate screening and assessment for glycemia and associated comorbidities and review safety, efficacy, mechanisms of action, and place for non-insulin therapies within the treatment algorithm.
This activity was developed from the live Best Practices in Primary Care™ program held in Chicago, Illinois on June 21, 2014. The expert faculty will discuss the strategies pertaining to appropriate initiation and intensification of insulin therapy.
Hypogonadism is an underdiagnosed syndrome with links to age, obesity, type 2 diabetes mellitus (T2DM), and metabolic syndromes. This activity will help clinicians with appropriate screening, diagnosis, and available testosterone supplemental therapies.
One of every two Caucasian women in the United States will have an osteoporotic fracture in their lifetime; one out of every 5 men in the United States will have an osteoporotic fracture in their lifetime. This activity will educate the participant on the updated guidelines to assess patients in proper diagnosis and management of osteoporosis.
Many elderly adults and their loved ones have not given serious consideration to how their lives may end and how they will manage and react when that time comes. Advance directives are the key to being prepared.
Listen and view the videos of Dr. William Wierda of MD Anderson Cancer Center and Dr. Brian Koffman in the discussion of immunity in Chronic Lymphocytic Leukemia (CLL) and how it relates to the emerging immune therapies now underway in clinical trials. In a second interview Dr. Wierda discusses new and old prognostic factors in CLL.
This CME activity will provide a foundation for the current science while discussing critical evaluation strategies for overactive bladder prior to therapy and provide the opportunity to earn up to 2.0 AMA PRA Category 1 Credits.